Search

everythinglearnresearchcommunity

for

Search:↓

Chromosomal microarray analysis is important for diagnosing rare genetic variations and guiding treatment.

Blood tests confirmed a baby in the womb had a CMV infection.

CK 15, follistatin, and Bmi-1 can help differentiate basal cell carcinoma from squamous cell carcinoma.

Coinheritance of BRCA2 and CYLD genes may lead to new treatment options for certain cancers.

The folate-cyclodextrin conjugate targets cancer cells more precisely, potentially reducing chemotherapy side effects.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

Enhancing Tregs can protect against alopecia areata.

No CD44 in alopecia areata, present in normal and androgenetic alopecia.

CD2 might be a new treatment target for patchy alopecia areata.

Farudodstat may effectively treat alopecia areata without harmful side effects.

CD25+ CD4+ Tregs and certain plasma proteins are linked to hair loss.

Expanded CD8+ T cells are linked to Alopecia Areata and may cause relapse after treatment.

A new TP63 mutation was found in a baby with EEC syndrome, showing the need for TREC testing to check for immune issues.

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.

Cats likely have a reactive skin condition, while dogs may have a more complex, possibly cancerous one.

ALRN-6924 may prevent hair loss caused by chemotherapy.

ARQ-234, a protein designed to treat atopic dermatitis, shows increased effectiveness in early testing.

INTASYL is a promising, adaptable RNAi technology for treating skin cancers.

High-content screening is useful for finding new treatments for rare diseases and has led to FDA-approved drugs.

Donor lymphocyte infusions effectively treated leukemia relapse but caused vitiligo and alopecia areata.

Hematopoietic stem cell transplantation does not significantly affect COVID-19 severity in children with immune disorders.

The patient with both scarring and non-scarring hair loss showed complex immune reactions and improved with steroid treatment.

Skin disorders in HIV patients have shifted, with more sexually transmitted infections and ART-related conditions now common.

A man got six skin cancers within a year after a cell transplant for leukemia but was cancer-free 32 months later; skin checks are important post-transplant.

A deletion in the CDH3 gene causes a rare disorder with short hair and vision loss.

Disitamab vedotin and gemcitabine effectively treated bladder cancer without major side effects.

Skin organoids with NCSTN mutation show changes in hair follicle development and higher inflammation, key features of Hidradenitis Suppurativa.

Canine hair follicles have stem cells in the bulge region.

HNG may help prevent the negative effects of chemotherapy on sperm production and white blood cell counts.